(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Recent experimental and clinical progress in the evaluation of cytokines in treatment concepts for cancer patients is the central theme of this book in the ESO Monographs series. The discussion revolves on the experimental basis as well as current clinical experience with the use of human recombinant cytokines. It gives the state of the art and, as such, puts into perspective potential areas of growth and future research.
Contents:
Interleukins and Haematopoietic Growth Factors.- Mechanisms of T-Cell Activation.- Characteristics of LAK Cells and their use in Adoptive Therapy of Cancer in Experimental Animals.- Interleukin 2: In Vivo Induction of Effector Cells.- Cellular Immunotherapy of Cancer: The use of Lymphokine-Activated Natural Killer (LANAK) Cells.- Interleukin 2: Clinical Aspects.- Interleukin 2 and LAK Cells.
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Publication date: November, 2011
Pages: 97
Weight: 275g
Availability: Available
Subcategories: Haematology, Immunology, Oncology
From the same series
